Evidence map›Paper›PMID 28630303›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2017

How members of the human gut microbiota overcome the sulfation problem posed by glycosaminoglycans.

Alan Cartmell, Elisabeth C Lowe, Arnaud Baslé, Susan J Firbank, Didier A Ndeh, Heath Murray, Nicolas Terrapon, Vincent Lombard, Bernard Henrissat, Jeremy E Turnbull and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 2 syntheses or guidelines pooled it, 150 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Chemoenzymatic Synthesis of AsymmetricJournal of the American Chemical Society · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Degradation of mucinbioRxiv : the preprint server for biology · 2026
    Article
  13. Article
  14. Chondroitin sulfate degradation bolstersbioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Article
  17. Arylsulfamates inhibit colonic Bacteroidota growth through a sulfatase-independent mechanism.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  18. Review
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 3 countries.

Alan CartmellInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
Elisabeth C LoweInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
Arnaud BasléInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
Susan J FirbankInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
Didier A NdehInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
Heath MurrayInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
Nicolas TerraponArchitecture et Fonction des Macromolécules Biologiques, CNRS, Aix-Marseille University, F-13288 Marseille, France.
Vincent LombardArchitecture et Fonction des Macromolécules Biologiques, CNRS, Aix-Marseille University, F-13288 Marseille, France.
Bernard HenrissatArchitecture et Fonction des Macromolécules Biologiques, CNRS, Aix-Marseille University, F-13288 Marseille, France.
Jeremy E TurnbullCentre for Glycobiology, Department of Biochemistry, Institute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, United Kingdom.
Mirjam CzjzekSorbonne Universités, Université Pierre-et-Marie-Curie, Université Paris 06, F-29688 Roscoff cedex, Bretagne, France.
Harry J GilbertInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom.
David N BolamInstitute for Cell and Molecular Biosciences, Newcastle University, Newcastle upon Tyne NE2 4HH, United Kingdom; david.bolam@ncl.ac.uk.
Newcastle University · GBCentre National de la Recherche Scientifique · FRUniversity of Liverpool · GB

Funding

Biotechnology and Biological Sciences Research Council BB/F014163/1European Research Council 322820Wellcome Trust 204985/Z/16/ZWellcome Trust WT097907MA
6 · The paper itself

Abstract

The human microbiota, which plays an important role in health and disease, uses complex carbohydrates as a major source of nutrients. Utilization hierarchy indicates that the host glycosaminoglycans heparin (Hep) and heparan sulfate (HS) are high-priority carbohydrates for

Indexed as

Gastrointestinal MicrobiomeBacteroidesCalorimetryCarbohydratesCatalysisCrystallography, X-RayCytoplasmDietary CarbohydratesGlycosaminoglycansHeparan SulfateHeparinHumansMicroscopy, FluorescenceMutationOligosaccharidesPolysaccharide-LyasesCarbohydratesDietary CarbohydratesGlycosaminoglycansHeparan SulfateHeparinOligosaccharidesPolysaccharide-LyasesPolysaccharidesSulfatasesSulfurBacteroides thetaiotaomicronglycosaminoglycan degradationheparan sulfateheparinhuman gut microbiota

Identifiers

PMID28630303
PMCPMC5502631
OpenAlexW2730311072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.